W4237157493
Manja Wobus, Reshma A. Rangwala, Irena Sheyn et al. · Applied Immunohistochemistry · 2002
Cited by 13 works. doi:10.1097/00022744-200203000-00006
Authors
- Manja Wobus
- Reshma A. Rangwala
- Irena Sheyn
- Robert F. Hennigan
- Brigit Coila
- Elyse E. Lower
- Rawia S. Yassin
- Larry S. Sherman
References
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
- Prognostic Factors in Breast Cancer
- Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors.
- ErbB‐2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling
- A Hierarchical Network of Interreceptor Interactions Determines Signal Transduction by Neu Differentiation Factor/Neuregulin and Epidermal Growth Factor
- Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family.
- Biochemical and Clinical Implications of the ErbB/HER Signaling Network of Growth Factor Receptors
- Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts
- neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group.